58 min listen
Ep 297 Frankly Speaking: Under Armour, Altius and the Biotech’s
FromWall Street Unplugged - What's Really Moving These Markets
Ep 297 Frankly Speaking: Under Armour, Altius and the Biotech’s
FromWall Street Unplugged - What's Really Moving These Markets
ratings:
Length:
27 minutes
Released:
Mar 27, 2015
Format:
Podcast episode
Description
We start off today with a question from Tom on Under Armour. Frank’s a fan and gives you his reasons why
Frank then covers his past recommendation on Altius. Listen today to get his current call on this natural resource royalty company and that market as a whole.
Patrick asks Frank about how many of his positions make sense to own at any one time. Should he buy everything?
And Bob as Frank if his call on biotech was premature.
And Joan writes in to say thanks for the recommendation.
Please send in your questions here.
Plus, Franks brand new website is live at www.Frankcurzio.com and his new newsletter Disrupters and Dominators has launched. Go here to learn more about it.
Frank then covers his past recommendation on Altius. Listen today to get his current call on this natural resource royalty company and that market as a whole.
Patrick asks Frank about how many of his positions make sense to own at any one time. Should he buy everything?
And Bob as Frank if his call on biotech was premature.
And Joan writes in to say thanks for the recommendation.
Please send in your questions here.
Plus, Franks brand new website is live at www.Frankcurzio.com and his new newsletter Disrupters and Dominators has launched. Go here to learn more about it.
Released:
Mar 27, 2015
Format:
Podcast episode
Titles in the series (100)
Breaking down the markets with guests Braden Copeland and Richard Suttmeier: Braden is the editor of S&A Insider Strategist, a newsletter that focuses on insider buying. Richard is Chief Market Strategist at www.ValueEngine.com by Wall Street Unplugged - What's Really Moving These Markets